These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


238 related items for PubMed ID: 8317093

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Effects of mutations in constant regions 3 and 4 of envelope of simian immunodeficiency virus.
    Morrison HG, Kirchhoff F, Desrosiers RC.
    Virology; 1995 Jul 10; 210(2):448-55. PubMed ID: 7618279
    [Abstract] [Full Text] [Related]

  • 3. Lymphocyte-tropic simian immunodeficiency virus causes persistent infection in the brains of rhesus monkeys.
    Stephens EB, Liu ZQ, Zhu GW, Adany I, Joag SV, Foresman L, Berman NE, Narayan O.
    Virology; 1995 Nov 10; 213(2):600-14. PubMed ID: 7491784
    [Abstract] [Full Text] [Related]

  • 4. Basic amino acid residues in the V3 loop of simian immunodeficiency virus envelope alter viral coreceptor tropism and infectivity but do not allow efficient utilization of CXCR4 as entry cofactor.
    Meister S, Otto C, Papkalla A, Krumbiegel M, Pöhlmann S, Kirchhoff F.
    Virology; 2001 Jun 05; 284(2):287-96. PubMed ID: 11384227
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. The "V3" domain is a determinant of simian immunodeficiency virus cell tropism.
    Kirchhoff F, Mori K, Desrosiers RC.
    J Virol; 1994 Jun 05; 68(6):3682-92. PubMed ID: 8189506
    [Abstract] [Full Text] [Related]

  • 8. Importance of the intracytoplasmic domain of the simian immunodeficiency virus (SIV) envelope glycoprotein for pathogenesis.
    Luciw PA, Shaw KE, Shacklett BL, Marthas ML.
    Virology; 1998 Dec 05; 252(1):9-16. PubMed ID: 9875311
    [Abstract] [Full Text] [Related]

  • 9. Mutational analysis of the conserved cysteine residues in the simian immunodeficiency virus matrix protein.
    González SA, Affranchino JL.
    Virology; 1995 Jul 10; 210(2):501-7. PubMed ID: 7618287
    [Abstract] [Full Text] [Related]

  • 10. Mutations at the C-terminus of the simian immunodeficiency virus envelope glycoprotein affect gp120-gp41 stability on virions.
    Affranchino JL, González SA.
    Virology; 2006 Mar 30; 347(1):217-25. PubMed ID: 16380144
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Determinants within gp120 and gp41 contribute to CD4 independence of SIV Envs.
    Puffer BA, Altamura LA, Pierson TC, Doms RW.
    Virology; 2004 Sep 15; 327(1):16-25. PubMed ID: 15327894
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. A simian human immunodeficiency virus with a nonfunctional Vpu (deltavpuSHIV(KU-1bMC33)) isolated from a macaque with neuroAIDS has selected for mutations in env and nef that contributed to its pathogenic phenotype.
    Singh DK, McCormick C, Pacyniak E, Lawrence K, Dalton SB, Pinson DM, Sun F, Berman NE, Calvert M, Gunderson RS, Wong SW, Stephens EB.
    Virology; 2001 Mar 30; 282(1):123-40. PubMed ID: 11259196
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Antigenic variation of SIV: mutations in V4 alter the neutralization profile.
    Kinsey NE, Anderson MG, Unangst TJ, Joag SV, Narayan O, Zink MC, Clements JE.
    Virology; 1996 Jul 01; 221(1):14-21. PubMed ID: 8661410
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. The effect of low-profile serine substitutions in the V3 loop of HIV-1 gp120 IIIB/LAI on the immunogenicity of the envelope protein.
    Peet NM, McKeating JA, de Souza JB, Roitt IM, Delves PJ, Lund T.
    Virology; 1998 Nov 10; 251(1):59-70. PubMed ID: 9813203
    [Abstract] [Full Text] [Related]

  • 20. A simian immunodeficiency virus V3 loop mutant that does not efficiently use CCR5 or common alternative coreceptors is moderately attenuated in vivo.
    Pöhlmann S, Münch J, Aziz S, Reeves JD, Otto C, Leslie GJ, Hofmann H, Puffer BA, Baribaud F, Marzi A, Gramberg T, Chen Z, Stolte N, Haaft PT, Heeney JL, Stahl-Hennig C, Mätz-Rensing K, Schneider T, Doms RW, Kirchhoff F.
    Virology; 2007 Apr 10; 360(2):275-85. PubMed ID: 17126374
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 12.